Navigation Links
Study of 137 Meniscus Transplant Procedures in Patients with Arthritis is Presented to the Meniscus Transplantation Study Group at the American Academy of Orthopaedic Surgeons Annual Meeting
Date:3/6/2008

Follow-Up Study Supports Biologic Joint Reconstruction Rather Than

Artificial Total Knee Replacement

SAN FRANCISCO, March 6 /PRNewswire/ -- In a report to the meeting of the Meniscus Transplantation Study Group, presented during the 2008 meeting of the American Academy of Orthopaedic Surgeons, Kevin R. Stone, M.D., of the Stone Research Foundation, San Francisco, presented an update on the outcome of 137 patients with arthritis who have undergone allograft replacement procedures of the meniscus since 1997.

In the follow-up study of objective clinical evaluation and imaging of the knee and the patients' subjective evaluation, 111 patients experienced successful outcomes after periods ranging from three months to 10.5 years. The failure rate was 19% with a mean time to failure of 4.79 years.

The allograft replacement procedure replaces the meniscus with a donor allograft. The procedure, which is used to protect the articular cartilage and/or reduce pain, is performed on an outpatient basis and is done arthroscopically and is, therefore, minimally invasive.

"The importance of this study," according to Dr. Stone, "is that it documents that meniscus replacement is an excellent option for some patients facing artificial total knee replacement. It can reduce patient pain and also delay the necessity for total replacement."

"The study also showed," he said, "that meniscal allograft transplantation is a viable treatment option for arthritic patients of all ages."

Among the unexpected study results was the variation in the objective and subjective evaluations of the procedure's success. In some cases, patients reported reduced or no pain when the objective evaluation and imaging seemed to indicate significant arthritis.

"Thus, subjective patient outcomes are critical in evaluating the success of the procedure," said Dr. Stone.

About The Stone Research Foundation

The Stone Research Foundation engages in research, development and education to prevent, treat and reverse arthritis and joint injuries. Its goal is to find minimally invasive biologic joint replacement treatments. It seeks to harness natural healing and regenerative capacities to reconstruct joints damaged by arthritis and injury. The Stone Research Foundation is a non-profit 501( c )3 organization (Tax I.D. # 94-3228007).

For more information, please contact:

Stephanie Stern, Stern & Co. at 212 888-0044


'/>"/>
SOURCE Stone Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New study sheds light on excessive drinking among the elderly
2. When it comes to emotions, Eastern and Western cultures see things very differently: Study
3. Aromatherapy Falls Short, Study Finds
4. New Study: Aging Baby Boomers Could Overwhelm U.S. Health Care System by 2017, Unless Decisive Action Is Taken
5. Carnegie Mellon study shows just listening to cell phones significantly impairs drivers
6. Southgate Community Schools To Present Studywiz Spark at Michigan Computer Users in Learning (MACUL) Conference
7. WHI follow-up study: Risks of long-term hormone therapy continue to outweigh benefits
8. Diamonds Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers Health and Wealth Needs
9. Study shows cholesterol-lowering power of dietitian visits
10. Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study
11. Genome-wide association study on Parkinsons disease finds public home at NIH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: